Dr. Hanah Lamallem was born on 6th September 1976 in Corbeil-Essones.
She studied medicine at the Paris-Descartes Faculty of Medicine (UFR NECKER) and embarked on her internship in the Paris hospitals in 2001. During her internship she specialized in medical oncology (at the Paul Brousse, the Institut Gustave Roussy and Cochin Hospitals), in radiotherapy (at the Institut Gustave Roussy, Pitié-Salpétrière and Georges Pompidou European Hospitals) and finally, completed her training, with a course on medical imagery and nuclear medicine, at the Centre René Huguenin.
From 2006 to 2008, she was Chef de Clinique Assistante (Assistant Senior Lecturer) in the radiotherapy department at the Hôpital Européen Georges Pompidou as well as at the Paris René Descartes University. During this period she studied the technique of intensity modulation and stereotaxic radiotherapy. She also followed a course on onco-geriatrics.
Dr. Lamallem has an M.Sc. in immunology and onco-genesis. After a year doing fundamental research into cellular biology at the prestigious University of Yale, U.S.A., she obtained a Master degree.
Dr. Lamallem has given lectures to medical students on Digestive Oncology (Cochin, Pr. Dousset), Gynecological Oncology (HEGP, Pr. Lecuru), Additional Care (HEGP, Pr. Oudard), and to Electro-technicians during their course at the Pitié-Salpétrière Hospital.
She is a member of the editorial staff of the France Cancer journal.
Dr. Lamallem is an active participant in various association : AERIO ( Association pour l’Enseignement et la Recherche des Internes en Oncologie – Oncology Interns’ Association for Teaching and Research ), as treasurer and member of the scientific committee of CORP (Club des Oncologues Radiothérapeutes Parisiens – Paris Oncologists and Radiotherapists’ Club ), and SCOP – the Cancerology Care Network.
Since 2009, Dr. Lamallem has been at the Centre de Radiothérapie Hartmann and the Hôpital Américain de Paris in partnership with Dr. Alain Toledano and Dr. Marc Bollet. Alongside her deep interest in innovation, research into oncology and the latest techniques in radiotherapy, her main concern is to give her patients individualized and humane medical care.
- [Place of hypofractionated radiotherapy in the treatment of prostate cancer: a review].
Toledano A, Beley S, Bollet M, Lamallem H, Zerbib M, Rouprêt M.
Prog Urol. 2012 Oct;22(12):671-7. doi: 10.1016/j.purol.2012.04.002. Epub 2012 May 10. French.
- [Elevation of PSA after prostate radiotherapy: rebound or biochemical recurrence?]. Toledano A, Chiche R, Lamallem H, Kanoui A, Beley S, Thibault F, Sèbe P.
Prog Urol. 2008 Oct;18(9):557-61. doi: 10.1016/j.purol.2008.06.001. Epub 2008 Jul 26. Review. French.
- Management of dyspnea in the cancer patient].
Lamallem H, Margery J, Ruffié P, Di Palma M.
Bull Cancer. 2003 Mar;90(3):214-8. Review. French.
More publications on PubMed.gov